InnovAge Holding (INNV) Resumen de Acciones
InnovAge Holding Corp. gestiona y presta una serie de servicios médicos y auxiliares a personas mayores que necesitan cuidados y apoyo para vivir de forma independiente en sus hogares y comunidades. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 4/6 |
| Crecimiento futuro | 4/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 5/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en INNV a partir de nuestros controles de riesgos.
INNV Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de InnovAge Holding Corp.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$11.10 |
| Máximo en las últimas 52 semanas | US$12.64 |
| Mínimo de 52 semanas | US$3.41 |
| Beta | 0.40 |
| Cambio en 1 mes | -3.48% |
| Variación en 3 meses | 47.80% |
| Cambio de 1 año | 215.34% |
| Variación en 3 años | 102.19% |
| Variación en 5 años | -25.30% |
| Variación desde la OPV | -54.13% |
Noticias y actualizaciones recientes
Actualización de narrativa • Jun 19
INNV: Unchanged Assumptions And 2026 Guidance Will Restrain Stock Upside
Analysts have kept their fair value estimate for InnovAge Holding steady at $7.00 per share, reflecting largely unchanged assumptions for the discount rate, revenue growth, profit margin, and future P/E in their updated price target work. What’s in the News for InnovAge Holding InnovAge Holding issued updated corporate guidance for fiscal 2026, providing investors with a more detailed view of expected performance.Actualización de narrativa • Jun 05
INNV: 2026 Guidance And Margin Outlook Will Shape Balanced Risk Reward
Analysts have kept their price target on InnovAge Holding steady at $7.00, pointing to slightly lower modeled revenue growth, a higher projected profit margin, and a modestly reduced future P/E assumption as key drivers of the updated view. What's in the News InnovAge Holding raised earnings guidance for fiscal 2026, with total revenues now expected in a range of US$950 million to US$975 million.Actualización de narrativa • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.Recent updates
Actualización de narrativa • Jun 19
INNV: Unchanged Assumptions And 2026 Guidance Will Restrain Stock Upside
Analysts have kept their fair value estimate for InnovAge Holding steady at $7.00 per share, reflecting largely unchanged assumptions for the discount rate, revenue growth, profit margin, and future P/E in their updated price target work. What’s in the News for InnovAge Holding InnovAge Holding issued updated corporate guidance for fiscal 2026, providing investors with a more detailed view of expected performance.Actualización de narrativa • Jun 05
INNV: 2026 Guidance And Margin Outlook Will Shape Balanced Risk Reward
Analysts have kept their price target on InnovAge Holding steady at $7.00, pointing to slightly lower modeled revenue growth, a higher projected profit margin, and a modestly reduced future P/E assumption as key drivers of the updated view. What's in the News InnovAge Holding raised earnings guidance for fiscal 2026, with total revenues now expected in a range of US$950 million to US$975 million.Actualización de narrativa • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.Actualización de narrativa • Apr 20
INNV: Updated Modeling And 2026 Guidance Will Likely Limit Future Share Upside
Analysts raised their price target on InnovAge Holding to $7 from $5, citing updated company modeling as the key driver of the change. Analyst Commentary The move to a US$7 price target signals that at least one major firm sees enough change in the underlying assumptions to justify a higher valuation for InnovAge Holding, even while keeping a cautious stance on the stock.Actualización de narrativa • Apr 05
INNV: Updated Modeling And 2026 Guidance Will Likely Temper Upside Expectations
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions that incorporate refined views on fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary JPMorgan's updated price target signals a fresh look at InnovAge Holding's valuation framework, even as the firm maintains an Underweight stance.Actualización de narrativa • Mar 22
INNV: Raised Outlook And Model Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated models that refine assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts view the lift in the price target to $7 as a sign that updated assumptions on fair value and discount rates support a higher implied equity valuation.Actualización de narrativa • Mar 08
INNV: Raised Outlook And P/E Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions around fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a modestly higher valuation framework. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a US$7 price target as recognition that updated fair value work supports a somewhat higher valuation range than before.Seeking Alpha • Feb 23
InnovAge: The Headwinds Are Priced In, The Growth May Not Be
Summary InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV’s revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%. Despite Medicaid eligibility headwinds, INNV’s improved processes and in-house pharmacy transition support a bullish outlook on sustainability and leverage. Read the full article on Seeking AlphaActualización de narrativa • Feb 21
INNV: Future Margin Assumptions Will Likely Prove Overly Optimistic
Analysts have revised their price target on InnovAge Holding, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these factors result in a new target of $7.00, up from $5.00.Artículo de análisis • Feb 06
Earnings Beat: InnovAge Holding Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
InnovAge Holding Corp. ( NASDAQ:INNV ) investors will be delighted, with the company turning in some strong numbers...Artículo de análisis • Jan 17
InnovAge Holding Corp.'s (NASDAQ:INNV) Price In Tune With Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.9x right...Artículo de análisis • Dec 13
InnovAge Holding (NASDAQ:INNV) Might Be Having Difficulty Using Its Capital Effectively
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...Artículo de análisis • Nov 07
InnovAge Holding Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
As you might know, InnovAge Holding Corp. ( NASDAQ:INNV ) just kicked off its latest quarterly results with some very...Artículo de análisis • Nov 03
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Artículo de análisis • Sep 10
Improved Revenues Required Before InnovAge Holding Corp. (NASDAQ:INNV) Stock's 32% Jump Looks Justified
InnovAge Holding Corp. ( NASDAQ:INNV ) shareholders would be excited to see that the share price has had a great month...Artículo de análisis • Jul 08
Health Check: How Prudently Does InnovAge Holding (NASDAQ:INNV) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Nueva narrativa • May 29
Expanding US Senior Care Integration Will Drive Healthcare Transformation
Enrollment growth and efficient geographic expansion are positioning the company for sustained revenue gains and scalable growth.Artículo de análisis • May 09
After Leaping 36% InnovAge Holding Corp. (NASDAQ:INNV) Shares Are Not Flying Under The Radar
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 36% after a shaky period...Artículo de análisis • Apr 09
Is InnovAge Holding (NASDAQ:INNV) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Artículo de análisis • Feb 06
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.6x may look like a pretty appealing...Artículo de análisis • Nov 07
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x seems...Artículo de análisis • Aug 20
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Artículo de análisis • Jun 28
InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 30% after a shaky period...Artículo de análisis • May 07
Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.8x right...Artículo de análisis • Mar 15
InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Artículo de análisis • Jan 06
Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)
There wouldn't be many who think InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x is...Rentabilidad de los accionistas
| INNV | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 8.5% | -0.4% | -0.3% |
| 1Y | 215.3% | 24.7% | 19.9% |
Rentabilidad vs. Industria: INNV superó a la industria US Healthcare, que obtuvo un rendimiento del 24.8% el año pasado.
Rentabilidad vs. Mercado: INNV superó al mercado US, que obtuvo un rendimiento del 18.9% el año pasado.
Volatilidad de los precios
| INNV volatility | |
|---|---|
| INNV Average Weekly Movement | 7.2% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: INNV no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de INNV (7%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1989 | 2,440 | Patrick Blair | www.innovage.com |
InnovAge Holding Corp. gestiona y presta una serie de servicios médicos y auxiliares a personas mayores que necesitan cuidados y apoyo para vivir de forma independiente en sus hogares y comunidades. Gestiona su negocio mediante el enfoque del Programa de Atención Integral a las Personas Mayores (PACE). La empresa también ofrece servicios de atención a domicilio consistentes en atención especializada, no especializada y personal; servicios en el centro, como atención primaria, fisioterapia, terapia ocupacional, logopedia, servicios dentales, servicios de salud mental y psiquiátricos, comidas y actividades; transporte de ida y vuelta al centro PACE y a citas médicas de terceros; y gestión de la atención.
Resumen de fundamentos de InnovAge Holding Corp.
| Estadísticas fundamentales de INNV | |
|---|---|
| Capitalización bursátil | US$1.45b |
| Beneficios(TTM) | -US$11.61m |
| Ingresos (TTM) | US$949.17m |
1.6x
Ratio precio-ventas (PS)-129.8x
Ratio precio-beneficio (PE)¿Está INNV sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de INNV | |
|---|---|
| Ingresos | US$949.17m |
| Coste de los ingresos | US$300.41m |
| Beneficio bruto | US$648.76m |
| Otros gastos | US$660.37m |
| Beneficios | -US$11.61m |
Últimos beneficios comunicados
Mar 31, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.086 |
| Margen bruto | 68.35% |
| Margen de beneficio neto | -1.22% |
| Ratio deuda/patrimonio | 22.4% |
¿Cómo se ha desempeñado INNV a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/08/18 05:04 |
| Precio de las acciones al final del día | 2026/08/18 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/06/30 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
InnovAge Holding Corp. está cubierta por 14 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |